LUMOS PHARMA IS COMMITTED TO DEVELOPING MEDICINES THAT WILL HAVE A HIGH IMPACT ON LIVES OF PATIENTS WITH RARE DISEASES.
A clinical trial involves research using human volunteers (trial participants, including healthy volunteers or patients), and is intended to answer specific questions about potential new treatments for certain diseases. These studies allow us to evaluate whether potential new treatments are safe and effective.
An observational study involves observing patients and the outcomes of the observations are recorded by the investigators. These studies are especially useful in rare disease drug development because the natural history of the disease is not well characterized, outcome measures are unknown, there are no prior trials from which to draw information and they offer an opportunity to gather patient and caregiver input and concerns.
Visit clinicaltrials.gov to learn more about eligibility to participate in a study, risks and benefits of study participation, the informed consent process, questions to ask when considering whether to participate in a study.
Lumos Pharma’s Clinical Programs
Pediatric Growth Hormone Deficiency Trials
FUTURE: PHASE 2b/STUDY (LUM-201)